Tag: Small Pharma - Page 3 - Psychedelic Alpha

Read more about the article Small Pharma to Participate in November Investor and Healthcare Conferences

Small Pharma to Participate in November Investor and Healthcare Conferences

Post published:November 29, 2022
Post category:Press Release

Read more about the article Small Pharma Receives Approval for First-In-Human Phase I Clinical Trial With SPL028

Small Pharma Receives Approval for First-In-Human Phase I Clinical Trial With SPL028

Post published:October 31, 2022
Post category:Press Release

Read more about the article Second United States Patent Granted for Small Pharma’s Psychedelics Portfolio

Second United States Patent Granted for Small Pharma’s Psychedelics Portfolio

Post published:October 19, 2022
Post category:Press Release

Read more about the article Small Pharma Reports Fiscal Second Quarter 2023 Highlights

Small Pharma Reports Fiscal Second Quarter 2023 Highlights

Post published:October 15, 2022
Post category:Press Release

Read more about the article Interview | George Tziras, Small Pharma

Interview | George Tziras, Small Pharma

Post published:October 4, 2022
Post category:Interview

Read more about the article Small Pharma Completes Enrollment in Phase IIa DMT-Assisted Psychotherapy Clinical Trial in Patients With Major Depressive Disorder

Small Pharma Completes Enrollment in Phase IIa DMT-Assisted Psychotherapy Clinical Trial in Patients With Major Depressive Disorder

Post published:September 19, 2022
Post category:Press Release

Read more about the article Small Pharma Enters Into Automatic Share Purchase Plan

Small Pharma Enters Into Automatic Share Purchase Plan

Post published:September 13, 2022
Post category:Press Release

Read more about the article Small Pharma to Participate in Upcoming September Investor Conferences

Small Pharma to Participate in Upcoming September Investor Conferences

Post published:September 8, 2022
Post category:Press Release

Read more about the article Small Pharma Announces TSXV Approval of Normal Course Issuer Bid

Small Pharma Announces TSXV Approval of Normal Course Issuer Bid

Post published:August 18, 2022
Post category:Press Release

Read more about the article Small Pharma Receives Approval for DMT-Assisted Psychotherapy and SSRI Drug Interaction Study

Small Pharma Receives Approval for DMT-Assisted Psychotherapy and SSRI Drug Interaction Study

Post published:August 15, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.